Y. Harano

976 total citations
37 papers, 816 citations indexed

About

Y. Harano is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Y. Harano has authored 37 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 14 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Molecular Biology. Recurrent topics in Y. Harano's work include Diet and metabolism studies (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Y. Harano is often cited by papers focused on Diet and metabolism studies (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Y. Harano collaborates with scholars based in Japan, United States and Russia. Y. Harano's co-authors include Y. Shigeta, Hideki Hidaka, S Ohgaku, Atsunori Kashiwagi, Hideto Kojima, Kenichiro Kosugi, Ryuichi Kikkawa, Hiroshi Abe, Michimasa Suzuki and Makoto Suzuki and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Y. Harano

37 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Harano Japan 15 351 289 252 168 128 37 816
Aubie Angel Canada 15 346 1.0× 279 1.0× 273 1.1× 339 2.0× 136 1.1× 32 1.0k
Yuzuru Ohshiro Japan 13 184 0.5× 211 0.7× 238 0.9× 100 0.6× 75 0.6× 20 784
Sidney S. Chernick United States 18 289 0.8× 469 1.6× 201 0.8× 137 0.8× 91 0.7× 23 1.0k
G. De Mattia Italy 11 216 0.6× 199 0.7× 117 0.5× 109 0.6× 162 1.3× 21 627
RA DeFronzo Italy 4 350 1.0× 309 1.1× 350 1.4× 226 1.3× 69 0.5× 5 779
Wanda Velez‐Carrasco United States 12 296 0.8× 345 1.2× 359 1.4× 258 1.5× 157 1.2× 13 963
Frances Rife United States 7 471 1.3× 436 1.5× 443 1.8× 199 1.2× 73 0.6× 8 1.2k
Myron L shank United States 9 384 1.1× 633 2.2× 322 1.3× 158 0.9× 137 1.1× 10 1.1k
V J Heiling United States 11 290 0.8× 375 1.3× 117 0.5× 115 0.7× 94 0.7× 13 677
J.R. Girard France 19 426 1.2× 583 2.0× 416 1.7× 346 2.1× 50 0.4× 36 1.5k

Countries citing papers authored by Y. Harano

Since Specialization
Citations

This map shows the geographic impact of Y. Harano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Harano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Harano more than expected).

Fields of papers citing papers by Y. Harano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Harano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Harano. The network helps show where Y. Harano may publish in the future.

Co-authorship network of co-authors of Y. Harano

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Harano. A scholar is included among the top collaborators of Y. Harano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Harano. Y. Harano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ryomoto, Kayoko, Michimasa Suzuki, Akio Kanazawa, et al.. (2000). Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension. American Journal of Hypertension. 13(6). 617–624. 5 indexed citations
3.
Takada, Mitsutaka, et al.. (2000). The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide. European Journal of Clinical Pharmacology. 56(4). 335–342. 7 indexed citations
4.
Suzuki, M., Akio Kanazawa, Masamitsu Hasegawa, & Y. Harano. (1999). Improvement of Insulin Resistance in Essential Hypertension by Long-Acting Ca Antagonist Benidipine. Clinical and Experimental Hypertension. 21(8). 1327–1344. 9 indexed citations
5.
Sato, Atsushi, Yukari Asakura, Chiaki Yokota, et al.. (1998). Lipoprotein disorder in brain infarction and hemorrhage. International Journal of Clinical & Laboratory Research. 28(1). 39–46. 8 indexed citations
7.
Aoki, Toshikazu, Hideki Hidaka, Kenichiro Kosugi, et al.. (1992). Increased Ketogenesis Related to Insulin Deficiency in Isolated Hepatocytes from NIDDM Model Rats. Hormone and Metabolic Research. 24(6). 258–262. 2 indexed citations
8.
Hidaka, Hideki, et al.. (1992). Suppressive Effect of Vasopressin on Ketosis in Diabetic Rats. Hormone and Metabolic Research. 24(1). 5–9. 5 indexed citations
9.
Harano, Y., Hideto Kojima, Kenichiro Kosugi, et al.. (1992). Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys. Diabetes Research and Clinical Practice. 16(3). 163–173. 13 indexed citations
10.
Harano, Y., Hideto Kojima, Takanari Nakano, et al.. (1989). Homozygous hypobetalipoproteinemia with spared chylomicron formation. Metabolism. 38(1). 1–7. 15 indexed citations
11.
Yasuda, Hiroshi, Yoshiaki Taniguchi, Ken’ichirou Kosugi, et al.. (1989). Chronically streptozocin-diabetic monkey does not closely mimic human diabetic neuropathy. Experimental Neurology. 104(2). 133–137. 7 indexed citations
12.
Hidaka, Hiroya, et al.. (1987). Study of Insulin Response to Oral Glucose Load After Acute and Chronic Glycemic Control in Type 2 Diabetic Subjects. Hormone and Metabolic Research. 19(3). 122–124. 1 indexed citations
13.
Yasuda, H., Y. Harano, Kenichiro Kosugi, et al.. (1984). Development of Early Lesions of Microangiopathy in Chronically Diabetic Monkeys. Diabetes. 33(5). 415–420. 15 indexed citations
14.
Harano, Y., Ken’ichirou Kosugi, Makoto Suzuki, et al.. (1984). Ketone bodies as markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control. Diabetologia. 26(5). 343–8. 31 indexed citations
15.
Kosugi, Ken’ichirou, Y. Harano, Atsunori Kashiwagi, Makoto Suzuki, & Y. Shigeta. (1984). Effect of insulin on the synthesis and release of lipid peroxide by cultured hepatocytes isolated from normal and diabetic rats. Cellular and Molecular Life Sciences. 40(4). 394–396. 6 indexed citations
16.
Kosugi, Ken’ichirou, Y. Harano, Takanari Nakano, et al.. (1983). Mechanism of adrenergic stimulation of hepatic ketogenesis. Metabolism. 32(11). 1081–1087. 26 indexed citations
17.
Harano, Y., Hideki Hidaka, S Ohgaku, et al.. (1978). Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism. 27(9). 1449–1452. 59 indexed citations
18.
Harano, Y., Akio Sakamoto, Kanji Izumi, et al.. (1977). Usefulness of maltose for testing glucose tolerance. American Journal of Clinical Nutrition. 30(6). 924–931. 5 indexed citations
19.
Rg, DePalma, et al.. (1970). Structure and function of hepatic mitochondria in hemorrhage and endotoxemia.. PubMed. 21. 3–6. 15 indexed citations
20.
Harano, Y., et al.. (1969). Fatty Acid Oxidation, Citric Acid Cycle Activity, and Morphology of Mitochondria in Diabetic Rat Liver. Experimental Biology and Medicine. 131(3). 913–917. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026